Question 1

What is the catalog number for ML234?

Accepted Answer

The catalog number for ML234 is orb2664912.

Question 2

What sizes are available for ML234?

Accepted Answer

ML234 is available in the following size(s): 50 mg, 10 mg.

Question 3

How many pack sizes does ML234 come in?

Accepted Answer

ML234 is available in 2 different pack sizes.

Question 4

Is ML234 in stock?

Accepted Answer

ML234 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is ML234 used for?

Accepted Answer

ML234 is a potent dual EZH2/LSD1 inhibitor with IC50 values of 0.09 and 0.12 μM, respectively. It exhibits robust antiproliferative activity against prostate cancer cell lines (LNCaP, PC3, 22RV1) and has demonstrated in vivo efficacy by inhibiting tumor growth in a 22RV1 xenograft model, supporting

Question 6

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 7

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

Question 8

What should I check when this product first arrives?

Accepted Answer

Inspect the package immediately for transportation damage, ice loss, leakage, or breakage. Report any issues right away with photos and your order reference; our specialists will determine whether the product is still usable or needs replacing.

ML234

Product Specifications

Field of Research

Storage Conditions

Notes

Available Sizes

Frequently Asked Questions

Explore Other Products

3,3-Dibromo-2-oxopropanoic Acid

YIPF2 Human Gene Knockout Kit (CRISPR)

Limaprost

Erlenmeyer Flasks

C8b Mouse Gene Knockout Kit (CRISPR)

CCDC98 Recombinant Rabbit Monoclonal Antibody [JE62-73]